PTC Therapeutics, Inc. (PTCT) Social Stream



PTC Therapeutics, Inc. (PTCT): $38.82

-1.25 (-3.12%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PTCT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 459

in industry

Ptc Therapeutics Inc (PTCT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Ptc Therapeutics Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
8 $85 $38 $58.625 $40.42 45.04%

The Trend in the Analyst Price Target


Over the past 16 months, PTCT's average price target has gone down $3.38.

PTCT reports an average of 42.12% for its upside potential over the past 18 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-08 8 85 38 58.625 41.25 42.12%
2020-05-31 NA 85 45 60.440 NA NA%

PTCT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 4 1 2 0 0 8

The Trend in the Broker Recommendations


Over the past 16 months, PTCT's average broker recommendation rating worsened by 0.3.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The variance in analysts' estimates of PTCT is lower than 11.26% of all US stocks.
  • Ptc Therapeutics Inc's average analyst price target is greater than 77.4% of Pharmaceutical Products stocks.
  • PTCT has a greater upside potential (average analyst target price relative to current price) than 24.7% of Pharmaceutical Products stocks.
  • PTCT has a higher number of analysts covering the stock than 72.29% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, BHC, FULC and NXTC are the three stocks most similar to Ptc Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is PTCT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.1004 seconds.